60 likes | 80 Views
Polycystic Ovarian Syndrome(PCOS) is a hormonal condition that affects about 6% to 8% o women of reproductive age worldwide.
E N D
Polycystic Ovarian Syndrome(PCOS) is a hormonal condition that affects about 6% to 8% o women of reproductive age worldwide. It is diagnosed by combination including high androgen (testosterone) levels seen on blood test and clinical features including: • Excess androgen: hirsutism (unwanted hair growth), acne or androgenic alopecia (scalp hair loss) • Menstrual dysfunction: abnormal uterine bleeding, amenorrhea (absent periods), oligomenorrhea (infrequent periods) • Polycystic ovaries (as seen on a pelvic ultrasound) What is PCOS?
Proper diet and exercise are very important lifestyle modifications to consider. Metformin may help with regulating a woman’s period because it improves insulin resistance and lowers testosterone levels. But the critical issue irregular periods, no periods and infertility is also linked to low progesterone production. Progesterone replacement is key in women with PCOS. Progesterone relays a message to the main control center of the ovaries — the hypothalamus and pituitary gland in your brain; and this message is to stop stimulating the ovaries in making so much testosterone. How is PCOS Treated?
If you have PCOS, taking bioidentical hormones such as micronized progesterone for 14 days every month may help get your hormones on the same page and naturally balanced. Treatment needs to go on for about three to six months to see results, in conjunction with proper diet and exercise. With time women with PCOS can get their natural hormone levels back on track. How Bioidentical Hormones Fit into PCOS?
Azziz R, Carmina E, Dewailly D et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. FertilSteril 2009 91(2):456-88. • Unfer V, Casini ML, Marelli G et al. Different routes of progesterone administration and polycystic ovarian syndrome: a review of the literature. Gynecological Endocrinology.2005;21(2): 119-127. • Sidney S, Siscovick DS, Petitti, DB et al. Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies. Circulation. 1998;98: 1058-1063. References